Damora Therapeutics, Inc.

NASDAQ:DMRA

Biotechnology

Healthcare
$22.98 +0.34%

+$0.07 today

Market cap
$1.42B
Beta
1.48
P/E (TTM)
-0.1
EPS (TTM)
-$177.15
52W Low $2.45High $38.33

Volume 0.58M

Average 0.33M

Price history

Damora Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+13.03%

Period high

$34.14

Period low

$16.31

Latest

$22.98

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 4, 2026Nov 4, 2026
4Sep 28, 2026Sep 28, 2026
4Aug 13, 2026Aug 13, 2026
3Aug 13, 2026Aug 13, 2026
EFFECTAug 12, 2026Aug 13, 2026
POS AMAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
10-QAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026
S-8 POSAug 10, 2026Aug 10, 2026

Competitors

Who does Damora Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DMRA's filings, answered from its disclosures.

What is the latest DMRA filing?

The latest filing shown is 10-Q dated Nov 4, 2026.

How many recent filings does DMRA have?

Intrinsic Alpha currently shows 20 recent filings for DMRA.